Last updated: April 25, 2026
Who Supplies Lasix (Furosemide) to the Market?
Lasix is the brand name for furosemide (loop diuretic). Because “Lasix” is a brand and not a molecule-only commodity, supply depends on (1) who holds marketing authorization in each jurisdiction, and (2) which manufacturer(s) are named as the drug substance and drug product supply chain on approved labeling, regulator submissions, and distributor listings. Those sourcing details are jurisdiction-specific and change over time.
What is “Lasix” legally in the supply chain?
- Drug substance: Furosemide (active pharmaceutical ingredient, API)
- Drug product: “Lasix” brand presentations (tablet and injectable forms in many markets)
For branded products, supply is typically split across:
- Marketing authorization holder (MAH) in the target country
- Finished dosage manufacturer (drug product site)
- API manufacturer(s) (drug substance site(s))
Because you asked only for “Suppliers,” the key business answer is: Lasix supply is provided through the MAH and their contracted drug product and API manufacturers, which vary by country and dosage form.
Which Suppliers Actually Matter for Lasix?
What do “suppliers” usually mean for an investor or R&D buyer?
For a branded liquid or solid oral/IV product like Lasix, “suppliers” typically means one or more of the following on the approved chain-of-identity:
- MAH / rights holder (who controls the dossier and commercialization)
- Drug product manufacturer (who makes the tablets/ampoules)
- API manufacturer(s) (who makes furosemide)
- Third-party logistics / distribution (who moves commercial lots)
Lasix Supplier Map by Component
1) Marketing authorization holder and brand commercialization
Lasix is manufactured and distributed under the brand by the company responsible for commercialization in each country. In the US, Lasix is marketed by Sanofi, and the product is widely available via multiple distributors, with manufacturing sites dependent on the specific lot and dosage form. (Brand and MAH positioning are visible on US prescribing information and product labeling.)
2) Finished dosage manufacturers (drug product sites)
For each commercial presentation (oral tablet vs injectable), the finished dosage manufacturing site can differ. In practice, retail and hospital supply chains use lots produced at one or more contracted manufacturing sites under the MAH’s quality system. Finished dosage suppliers can vary because of:
- site switching across supply contracts
- changes in manufacturing strategy
- responses to regulatory or capacity constraints
3) API manufacturers
Furosemide API is sourced globally. For branded “Lasix,” the API supplier(s) are the ones that feed the qualified finished dosage manufacturer under the MAH’s approved API specifications.
Market Access Reality: Why “Lasix suppliers” are not one fixed list
Why you see different manufacturers for the same Lasix brand
Even with the same brand name and strength, suppliers can differ across:
- country
- dosage form
- packaging configuration
- time period (lot / annual manufacturing changes)
In procurement, this means purchase orders are filled by the specific lot’s labeled manufacturer, not by a universal global manufacturer list.
What’s the actionable way to identify Lasix suppliers (commercially)?
Use the label-defined chain for the exact product you buy
The operational supplier list is determined by:
- the country-specific package insert / prescribing information
- the label section identifying manufacturer for drug product
- any drug product and API site disclosures required in that jurisdiction
This is the only method that produces a defensible supplier roster for contracting, QA, or investment diligence.
Key Takeaways
- Lasix is furosemide, and “suppliers” are not a single universal list; they are defined by MAH plus labeled drug product manufacturer(s) and, indirectly, qualified API sources.
- For business decisions, the supplier roster must be derived from the specific jurisdiction’s approved labeling for the exact Lasix presentation (tablet vs injectable) and strength.
- Contracting and diligence typically rely on the lot- and label-defined manufacturers, not on a generic “brand supplier” statement.
FAQs
1) Who makes Lasix tablets vs Lasix injection?
The drug product manufacturer can differ by dosage form and by country. The definitive maker for a given lot is identified on the product labeling in that jurisdiction.
2) Is furosemide API supplier the same everywhere?
No. Furosemide API supply is global and multiple sites qualify for branded finished products. The qualified API route is determined by the MAH’s approval and the finished dosage manufacturer’s quality system.
3) Does “Lasix supplier” mean MAH or manufacturer?
In procurement and diligence, it means both: the MAH controls commercialization, while the drug product manufacturer is the operational supplier named on labeling and in commercial documentation.
4) Can suppliers change without changing the brand name?
Yes. Contract manufacturing and quality-approved site changes can occur while the brand and strength remain the same.
5) How do hospitals and wholesalers verify Lasix suppliers?
They rely on lot-specific labeling and the commercial documentation tied to that lot (NDC/pack level), which identifies the manufacturer(s).
Sources
[1] FDA. “Furosemide (Lasix) Prescribing Information.” US prescribing information and labeling. U.S. Food and Drug Administration.
[2] Sanofi. “Lasix (furosemide) product information” (brand labeling and commercialization materials). Sanofi.
